Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation

Emanuela Gussoni, Richard R. Bennett, Kristina R. Muskiewicz, Todd Meyerrose, Jan Nolta, Irene Gilgoff, James Stein, Yiu Mo Chan, Hart G. Lidov, Carsten G. Bönnemann, Arpad Von Moers, Glenn E. Morris, Johan T. Den Dunnen, Jeffrey S. Chamberlain, Louis M. Kunkel, Kenneth Weinberg

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

Duchenne muscular dystrophy (DMD) is a severe progressive muscle-wasting disorder caused by mutations in the dystrophin gene. Studies have shown that bone marrow cells transplanted into lethally irradiated mdx mice, the mouse model of DMD, can become part of skeletal muscle myofibers. Whether human marrow cells also have this ability is unknown. Here we report the analysis of muscle biopsies from a DMD patient (DMD-BMT1) who received bone marrow transplantation at age 1 year for X-linked severe combined immune deficiency and who was diagnosed with DMD at age 12 years. Analysis of muscle biopsies from DMD-BMT1 revealed the presence of donor nuclei within a small number of muscle myofibers (0.5-0.9%). The majority of the myofibers produce a truncated, in-frame isoform of dystrophin lacking exons 44 and 45 (not wild-type). The presence of bone marrow-derived donor nuclei in the muscle of this patient documents the ability of exogenous human bone marrow cells to fuse into skeletal muscle and persist up to 13 years after transplantation.

Original languageEnglish (US)
Pages (from-to)807-814
Number of pages8
JournalJournal of Clinical Investigation
Volume110
Issue number6
DOIs
StatePublished - Sep 2002
Externally publishedYes

Fingerprint

Duchenne Muscular Dystrophy
Bone Marrow Transplantation
Tissue Donors
Muscles
Dystrophin
Bone Marrow Cells
Skeletal Muscle
Bone Marrow
Inbred mdx Mouse
Biopsy
Severe Combined Immunodeficiency
Muscular Diseases
Exons
Protein Isoforms
Transplantation
Mutation
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. / Gussoni, Emanuela; Bennett, Richard R.; Muskiewicz, Kristina R.; Meyerrose, Todd; Nolta, Jan; Gilgoff, Irene; Stein, James; Chan, Yiu Mo; Lidov, Hart G.; Bönnemann, Carsten G.; Von Moers, Arpad; Morris, Glenn E.; Den Dunnen, Johan T.; Chamberlain, Jeffrey S.; Kunkel, Louis M.; Weinberg, Kenneth.

In: Journal of Clinical Investigation, Vol. 110, No. 6, 09.2002, p. 807-814.

Research output: Contribution to journalArticle

Gussoni, E, Bennett, RR, Muskiewicz, KR, Meyerrose, T, Nolta, J, Gilgoff, I, Stein, J, Chan, YM, Lidov, HG, Bönnemann, CG, Von Moers, A, Morris, GE, Den Dunnen, JT, Chamberlain, JS, Kunkel, LM & Weinberg, K 2002, 'Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation', Journal of Clinical Investigation, vol. 110, no. 6, pp. 807-814. https://doi.org/10.1172/JCI200216098
Gussoni, Emanuela ; Bennett, Richard R. ; Muskiewicz, Kristina R. ; Meyerrose, Todd ; Nolta, Jan ; Gilgoff, Irene ; Stein, James ; Chan, Yiu Mo ; Lidov, Hart G. ; Bönnemann, Carsten G. ; Von Moers, Arpad ; Morris, Glenn E. ; Den Dunnen, Johan T. ; Chamberlain, Jeffrey S. ; Kunkel, Louis M. ; Weinberg, Kenneth. / Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. In: Journal of Clinical Investigation. 2002 ; Vol. 110, No. 6. pp. 807-814.
@article{8d062f48ea54401f9df6cfb664ca83c5,
title = "Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation",
abstract = "Duchenne muscular dystrophy (DMD) is a severe progressive muscle-wasting disorder caused by mutations in the dystrophin gene. Studies have shown that bone marrow cells transplanted into lethally irradiated mdx mice, the mouse model of DMD, can become part of skeletal muscle myofibers. Whether human marrow cells also have this ability is unknown. Here we report the analysis of muscle biopsies from a DMD patient (DMD-BMT1) who received bone marrow transplantation at age 1 year for X-linked severe combined immune deficiency and who was diagnosed with DMD at age 12 years. Analysis of muscle biopsies from DMD-BMT1 revealed the presence of donor nuclei within a small number of muscle myofibers (0.5-0.9{\%}). The majority of the myofibers produce a truncated, in-frame isoform of dystrophin lacking exons 44 and 45 (not wild-type). The presence of bone marrow-derived donor nuclei in the muscle of this patient documents the ability of exogenous human bone marrow cells to fuse into skeletal muscle and persist up to 13 years after transplantation.",
author = "Emanuela Gussoni and Bennett, {Richard R.} and Muskiewicz, {Kristina R.} and Todd Meyerrose and Jan Nolta and Irene Gilgoff and James Stein and Chan, {Yiu Mo} and Lidov, {Hart G.} and B{\"o}nnemann, {Carsten G.} and {Von Moers}, Arpad and Morris, {Glenn E.} and {Den Dunnen}, {Johan T.} and Chamberlain, {Jeffrey S.} and Kunkel, {Louis M.} and Kenneth Weinberg",
year = "2002",
month = "9",
doi = "10.1172/JCI200216098",
language = "English (US)",
volume = "110",
pages = "807--814",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation

AU - Gussoni, Emanuela

AU - Bennett, Richard R.

AU - Muskiewicz, Kristina R.

AU - Meyerrose, Todd

AU - Nolta, Jan

AU - Gilgoff, Irene

AU - Stein, James

AU - Chan, Yiu Mo

AU - Lidov, Hart G.

AU - Bönnemann, Carsten G.

AU - Von Moers, Arpad

AU - Morris, Glenn E.

AU - Den Dunnen, Johan T.

AU - Chamberlain, Jeffrey S.

AU - Kunkel, Louis M.

AU - Weinberg, Kenneth

PY - 2002/9

Y1 - 2002/9

N2 - Duchenne muscular dystrophy (DMD) is a severe progressive muscle-wasting disorder caused by mutations in the dystrophin gene. Studies have shown that bone marrow cells transplanted into lethally irradiated mdx mice, the mouse model of DMD, can become part of skeletal muscle myofibers. Whether human marrow cells also have this ability is unknown. Here we report the analysis of muscle biopsies from a DMD patient (DMD-BMT1) who received bone marrow transplantation at age 1 year for X-linked severe combined immune deficiency and who was diagnosed with DMD at age 12 years. Analysis of muscle biopsies from DMD-BMT1 revealed the presence of donor nuclei within a small number of muscle myofibers (0.5-0.9%). The majority of the myofibers produce a truncated, in-frame isoform of dystrophin lacking exons 44 and 45 (not wild-type). The presence of bone marrow-derived donor nuclei in the muscle of this patient documents the ability of exogenous human bone marrow cells to fuse into skeletal muscle and persist up to 13 years after transplantation.

AB - Duchenne muscular dystrophy (DMD) is a severe progressive muscle-wasting disorder caused by mutations in the dystrophin gene. Studies have shown that bone marrow cells transplanted into lethally irradiated mdx mice, the mouse model of DMD, can become part of skeletal muscle myofibers. Whether human marrow cells also have this ability is unknown. Here we report the analysis of muscle biopsies from a DMD patient (DMD-BMT1) who received bone marrow transplantation at age 1 year for X-linked severe combined immune deficiency and who was diagnosed with DMD at age 12 years. Analysis of muscle biopsies from DMD-BMT1 revealed the presence of donor nuclei within a small number of muscle myofibers (0.5-0.9%). The majority of the myofibers produce a truncated, in-frame isoform of dystrophin lacking exons 44 and 45 (not wild-type). The presence of bone marrow-derived donor nuclei in the muscle of this patient documents the ability of exogenous human bone marrow cells to fuse into skeletal muscle and persist up to 13 years after transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0036736786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036736786&partnerID=8YFLogxK

U2 - 10.1172/JCI200216098

DO - 10.1172/JCI200216098

M3 - Article

C2 - 12235112

AN - SCOPUS:0036736786

VL - 110

SP - 807

EP - 814

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -